Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
Eur Radiol. 2023 Jan;33(1):512-522. doi: 10.1007/s00330-022-08980-4. Epub 2022 Jul 21.
Eur Radiol. 2023.
PMID: 35864351
Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials.
Chen BB, Lin ZZ, Shao YY, Hsu C, Hsu CH, Cheng AL, Liang PC, Shih TT.
Chen BB, et al.
Cancers (Basel). 2021 Oct 1;13(19):4962. doi: 10.3390/cancers13194962.
Cancers (Basel). 2021.
PMID: 34638446
Free PMC article.
Item in Clipboard
Cite
Cite